ISM-3412
- Generic Name
- ISM-3412
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- InSilico Medicine Hong Kong Limited
- Target Recruit Count
- 80
- Registration Number
- NCT06414460
- Locations
- 🇺🇸
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
🇨🇳Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath